4 documents found, page 1 of 1
COPD and Cardiovascular Disease
André, S; Conde, B; Fragoso, E; Boléo-Tomé, JP; Areias, V; Cardoso, JCOPD is one of the major public health problems in people aged 40 years or above. It is currently the 4th leading cause of death in the world and projected to be the 3rd leading cause of death by 2020. COPD and cardiac comorbidities are frequently associated. They share common risk factors, pathophysiological processes, signs and symptoms, and act synergistically as negative prognostic factors. Cardiac disease ...
COPD and Cardiovascular Disease.
André, S; Conde, B; Fragoso, E; Boléo-Tomé, JP; Areias, V; Cardoso, J; GI DPOC-Grupo de Interesse na Doença Pulmonar Obstrutiva CrónicaCOPD is one of the major public health problems in people aged 40 years or above. It is currently the 4th leading cause of death in the world and projected to be the 3rd leading cause of death by 2020. COPD and cardiac comorbidities are frequently associated. They share common risk factors, pathophysiological processes, signs and symptoms, and act synergistically as negative prognostic factors. Cardiac disease ...
Understanding COPD: a vision on phenotypes, comorbidities and treatment approach.
Fragoso, E; André, S; Boléo-Tomé, JP; Areias, V; Munhá, J; Cardoso, J; GI DPOC-Grupo de Interesse na Doença Pulmonar Obstrutiva CrónicaChronic Obstructive Pulmonary Disease (COPD) phenotypes have become increasingly recognized as important for grouping patients with similar presentation and/or behavior, within the heterogeneity of the disease. The primary aim of identifying phenotypes is to provide patients with the best health care possible, tailoring the therapeutic approach to each patient. However, the identification of specific phenotypes...
Understanding COPD: A Vision on Phenotypes, Comorbidities and Treatment Approach
Fragoso, E; André, S; Boleo-Tomé, JP; Areias, V; Munhá, J; Cardoso, JChronic Obstructive Pulmonary Disease (COPD) phenotypes have become increasingly recognized as important for grouping patients with similar presentation and/or behavior, within the heterogeneity of the disease. The primary aim of identifying phenotypes is to provide patients with the best health care possible, tailoring the therapeutic approach to each patient. However, the identification of specific phenotypes...